Publicaciones en colaboración con investigadores/as de Harvard Medical School (7)

2025

  1. International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma

    Journal of Clinical Oncology, Vol. 43, Núm. 24, pp. 2739-2751

  2. Uncovering the regulatory landscape of early human B cell lymphopoiesis and its implications in the pathogenesis of B-ALL

    Science advances, Vol. 11, Núm. 41, pp. eadw3110

2023

  1. Cardiac Progenitor Cell Exosomal miR-935 Protects against Oxidative Stress

    Cells, Vol. 12, Núm. 18

  2. Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma

    Nature Medicine, Vol. 29, Núm. 3, pp. 632-645

2022

  1. WAT3R: recovery of T-cell receptor variable regions from 3′ single-cell RNA-sequencing

    Bioinformatics, Vol. 38, Núm. 14, pp. 3645-3647

2020

  1. Chromatin activation as a unifying principle underlying pathogenic mechanisms in multiple myeloma

    Genome Research, Vol. 30, Núm. 9, pp. 1217-1227

2017

  1. The Mutational Landscape of Circulating Tumor Cells in Multiple Myeloma

    Cell Reports, Vol. 19, Núm. 1, pp. 218-224